Erik Digman Wiklund
Chief Executive Officer bij CIRCIO HOLDING ASA
Oorsprong van het eerstegraads netwerk van Erik Digman Wiklund
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 24 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Erik Digman Wiklund via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
BIOGEN INC. | Pharmaceuticals: Major | Sales & Marketing | |
CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Operating Officer | |
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | General Counsel | |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Micreos BV
Micreos BV Pharmaceuticals: GenericHealth Technology Micreos BV develops phage-based products against specific dangerous bacteria. It offers human health, food safety, agriculture and animal health products. The company was founded by Mark Offerhaus and is headquartered in Wageningen, the Netherlands. | Pharmaceuticals: Generic | Chairman | |
SQZ BIOTECHNOLOGIES COMPANY | Biotechnology | Director/Board Member | |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Private Equity Investor Private Equity Investor | |
Odlander, Fredrikson & Co. AB
Odlander, Fredrikson & Co. AB Financial ConglomeratesFinance Odlander Fredrikson & Co. AB provides financial support services. The company was founded in 1996 and is headquartered in Stockholm, Sweden. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
SANTHERA PHARMACEUTICALS HOLDING AG | Pharmaceuticals: Major | Director/Board Member | |
ONCOPEPTIDES AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
University of Sussex | College/University | Undergraduate Degree | |
University of Oslo | College/University | Graduate Degree Doctorate Degree | |
University of Leiden | College/University | Doctorate Degree | |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor | |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Acacia Pharma Ltd.
Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Locust Walk Partners LLC
Locust Walk Partners LLC Miscellaneous Commercial ServicesCommercial Services Locust Walk Partners LLC provides commercial supporting and advisory services. The firm involves in securities-related transactions for clients, including mergers and acquisitions, private placements & mezzanine financings and partnerships involving equity investments. The company was founded by Geoff Meyerson and Joseph Mohr in 2008 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Healthcap 1999 GP AB
Healthcap 1999 GP AB Investment Banks/BrokersFinance Part of Odlander, Fredrikson & Co. AB, Healthcap 1999 GP AB is a private company that manages and trades securities. The company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member Director/Board Member | |
Glaxo Wellcome Immobilière de Recherche SA
Glaxo Wellcome Immobilière de Recherche SA Real Estate DevelopmentFinance Glaxo Wellcome Immobilière de Recherche SA provides real estate services. The company was founded in 1992 and is headquartered in Marly-le-Roi, France. | Real Estate Development | Corporate Officer/Principal | |
Bayer AS
Bayer AS Pharmaceuticals: MajorHealth Technology Bayer AS trades pharmaceutical products. It also provides animal health, crop science, and consumer health. The company was founded in 1964 and is headquartered in Lysaker, Norway. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
BiognoSYS AG
BiognoSYS AG Packaged SoftwareTechnology Services BiognoSYS AG operates as a biotechnology company. Its products include iRT Kit, HRM Kit, Sample Prep Kit, PlasmaDive, Spectronaut and SpectroDive. The company was founded by Philipp M. Antoni, Johan Malmstroem and Oliver Rinner on September 3, 2008 and is headquartered in Schlieren, Switzerland. | Packaged Software | Chairman | |
CANTARGIA AB | Pharmaceuticals: Major | Director/Board Member | |
Targovax Oy
Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Chairman | |
ARCH BIOPARTNERS INC. | Pharmaceuticals: Major | Director/Board Member | |
INHIBIKASE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
University of California | College/University | Doctorate Degree | |
SPERO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
ADVANZ PHARMA CORP. LIMITED | Pharmaceuticals: Major | Director/Board Member | |
University of Rochester Simon Business School | College/University | Masters Business Admin | |
PIQUR Therapeutics AG
PIQUR Therapeutics AG Pharmaceuticals: OtherHealth Technology PIQUR Therapeutics AG engages in development of anti-cancer drugs based on the inhibition. Its products include PQR309, PQR620 and PQR5xx. The company was founded by Bernd Giese, Vladimir Cmiljanovic, Andreas Emmenegger, Ralf Rosenow and Matthias Wymann in August 2011 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Other | Chairman | |
Ancilla AB
Ancilla AB Real Estate DevelopmentFinance Ancilla AB manages real properties. The company is headquartered in Stockholm, Sweden. | Real Estate Development | Director/Board Member Director/Board Member | |
ACACIA PHARMA GROUP PLC | Pharmaceuticals: Other | Chairman | |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
NMD Pharma A/S
NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Biotechnology | Chairman | |
Healthcap Aero Holdings Gp | Director/Board Member Director/Board Member | ||
Healthcap Orx Holdings Gp AB
Healthcap Orx Holdings Gp AB Investment Banks/BrokersFinance Healthcap Orx Holdings Gp AB is a private company that manages securities. The company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member Director/Board Member | |
Essential Pharmaceuticals Ltd.
Essential Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Essential Pharmaceuticals Ltd. manufactures pharmaceutical products. The company was founded on November 24, 2010 and is headquartered in Egham, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Gyrus Capital SA | Investment Managers | Private Equity Investor | |
AMRYT PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
TREX WIND-DOWN, INC. | Pharmaceuticals: Major | Director/Board Member | |
F2g Inc. | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 14 |
Zweden | 11 |
Verenigd Koninkrijk | 10 |
Noorwegen | 6 |
Zwitserland | 5 |
Sectoraal
Health Technology | 32 |
Finance | 10 |
Consumer Services | 7 |
Commercial Services | 2 |
Technology Services | 2 |
Operationeel
Director/Board Member | 143 |
Corporate Officer/Principal | 50 |
Chairman | 38 |
Independent Dir/Board Member | 30 |
Chief Executive Officer | 18 |
Sterkste connecties
- Beurs
- Insiders
- Erik Digman Wiklund
- Bedrijfsconnecties